Investors are concerned about the company's path to profitab...
Investors are concerned about the company's path to profitability. If growth slows, profitability will be delayed. The company's negative equity could be a warning, though these losses are usually only on paper.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Is Expected To Breakeven In The Near Future
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment